Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

88 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pharmacogenetics of anti-cancer drugs: State of the art and implementation - recommendations of the French National Network of Pharmacogenetics.
Quaranta S, Thomas F. Quaranta S, et al. Therapie. 2017 Apr;72(2):205-215. doi: 10.1016/j.therap.2017.01.005. Epub 2017 Jan 30. Therapie. 2017. PMID: 28262261 Review.
[Dihydropyrimidine déhydrogenase (DPD) deficiency screening and securing of fluoropyrimidine-based chemotherapies: Update and recommendations of the French GPCO-Unicancer and RNPGx networks].
Loriot MA, Ciccolini J, Thomas F, Barin-Le-Guellec C, Royer B, Milano G, Picard N, Becquemont L, Verstuyft C, Narjoz C, Schmitt A, Bobin-Dubigeon C, Harle A, Paci A, Poinsignon V, Quaranta S, Evrard A, Hennart B, Broly F, Fonrose X, Lafay-Chebassier C, Wozny AS, Masskouri F, Boyer JC, Etienne-Grimaldi MC. Loriot MA, et al. Among authors: quaranta s. Bull Cancer. 2018 Apr;105(4):397-407. doi: 10.1016/j.bulcan.2018.02.001. Epub 2018 Feb 24. Bull Cancer. 2018. PMID: 29486921 Review. French.
UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice.
Etienne-Grimaldi MC, Boyer JC, Thomas F, Quaranta S, Picard N, Loriot MA, Narjoz C, Poncet D, Gagnieu MC, Ged C, Broly F, Le Morvan V, Bouquié R, Gaub MP, Philibert L, Ghiringhelli F, Le Guellec C; Collective work by Groupe de Pharmacologie Clinique Oncologique (GPCO-Unicancer); French Réseau National de Pharmacogénétique Hospitalière (RNPGx). Etienne-Grimaldi MC, et al. Among authors: quaranta s. Fundam Clin Pharmacol. 2015 Jun;29(3):219-37. doi: 10.1111/fcp.12117. Epub 2015 May 4. Fundam Clin Pharmacol. 2015. PMID: 25817555
[Interest of UGT1A1 genotyping within digestive cancers treatment by irinotecan].
Boyer JC, Etienne-Grimaldi MC, Thomas F, Quaranta S, Picard N, Loriot MA, Poncet D, Gagnieu MC, Ged C, Broly F, Le Morvan V, Bouquié R, Gaub MP, Philibert L, Ghiringhelli F, Le Guellec C. Boyer JC, et al. Among authors: quaranta s. Bull Cancer. 2014 Jun;101(6):533-53. doi: 10.1684/bdc.2014.1933. Bull Cancer. 2014. PMID: 24977443 Review. French.
[Triazole antifungal agents: practice guidelines of therapeutic drug monitoring and perspectives in treatment optimization].
Scodavolpe S, Quaranta S, Lacarelle B, Solas C. Scodavolpe S, et al. Among authors: quaranta s. Ann Biol Clin (Paris). 2014 Jul-Aug;72(4):391-404. doi: 10.1684/abc.2014.0968. Ann Biol Clin (Paris). 2014. PMID: 25119797 Review. French.
Niveau de preuve du suivi therapeutique pharmacologique de la névirapine.
Muret P, Piedoux S, Solas C, Quaranta S; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Muret P, et al. Among authors: quaranta s. Therapie. 2011 May-Jun;66(3):187-95. doi: 10.2515/therapie/2011030. Therapie. 2011. PMID: 27393198 French.
[Clinical application, limits and perspectives of pharmacogenetic and pharmacokinetic analysis of anticancer drugs].
Chantry AS, Quaranta S, Ciccolini J, Lacarelle B. Chantry AS, et al. Among authors: quaranta s. Ann Biol Clin (Paris). 2014 Sep-Oct;72(5):527-42. doi: 10.1684/abc.2014.0993. Ann Biol Clin (Paris). 2014. PMID: 25336126 Review. French.
Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics.
Quaranta S, Dupouey J, Colle R, Verstuyft C. Quaranta S, et al. Therapie. 2017 Apr;72(2):311-318. doi: 10.1016/j.therap.2016.09.018. Epub 2017 Jan 30. Therapie. 2017. PMID: 28237405 Review.
Pharmacogénétique des médicaments antidépresseurs : état des connaissances et des pratiques – recommandations du Réseau national de pharmacogénétique (RNPGx).
Quaranta S, Dupouey J, Colle R, Verstuyft C. Quaranta S, et al. Therapie. 2017 Apr;72(2):301-309. doi: 10.1016/j.therap.2016.09.012. Epub 2017 Jan 3. Therapie. 2017. PMID: 28189334 French. No abstract available.
Niveau de preuve du suivi therapeutique pharmacologique de la ribavirine.
Solas C, Paré M, Quaranta S, Stanke-Labesque F; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Francaise de Pharmacologie et de Thérapeutique. Solas C, et al. Among authors: quaranta s. Therapie. 2011 May-Jun;66(3):221-30. doi: 10.2515/therapie/2011036. Therapie. 2011. PMID: 27393202 French.
88 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback